Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

140 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Late patient-reported toxicity after preoperative radiotherapy or chemoradiotherapy in nonresectable rectal cancer: results from a randomized Phase III study.
Brændengen M, Tveit KM, Bruheim K, Cvancarova M, Berglund Å, Glimelius B. Brændengen M, et al. Among authors: tveit km. Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):1017-24. doi: 10.1016/j.ijrobp.2010.07.007. Epub 2010 Oct 6. Int J Radiat Oncol Biol Phys. 2011. PMID: 20932687 Clinical Trial.
Late side effects and quality of life after radiotherapy for rectal cancer.
Bruheim K, Guren MG, Skovlund E, Hjermstad MJ, Dahl O, Frykholm G, Carlsen E, Tveit KM. Bruheim K, et al. Among authors: tveit km. Int J Radiat Oncol Biol Phys. 2010 Mar 15;76(4):1005-11. doi: 10.1016/j.ijrobp.2009.03.010. Epub 2009 Jun 18. Int J Radiat Oncol Biol Phys. 2010. PMID: 19540058
Sexual function in males after radiotherapy for rectal cancer.
Bruheim K, Guren MG, Dahl AA, Skovlund E, Balteskard L, Carlsen E, Fosså SD, Tveit KM. Bruheim K, et al. Among authors: tveit km. Int J Radiat Oncol Biol Phys. 2010 Mar 15;76(4):1012-7. doi: 10.1016/j.ijrobp.2009.03.075. Epub 2009 Oct 31. Int J Radiat Oncol Biol Phys. 2010. PMID: 19880263
Sexual function in females after radiotherapy for rectal cancer.
Bruheim K, Tveit KM, Skovlund E, Balteskard L, Carlsen E, Fosså SD, Guren MG. Bruheim K, et al. Among authors: tveit km. Acta Oncol. 2010 Aug;49(6):826-32. doi: 10.3109/0284186X.2010.486411. Acta Oncol. 2010. PMID: 20615170
Reirradiation of locally recurrent rectal cancer: a systematic review.
Guren MG, Undseth C, Rekstad BL, Brændengen M, Dueland S, Spindler KL, Glynne-Jones R, Tveit KM. Guren MG, et al. Among authors: tveit km. Radiother Oncol. 2014 Nov;113(2):151-7. doi: 10.1016/j.radonc.2014.11.021. Epub 2014 Nov 26. Radiother Oncol. 2014. PMID: 25613395 Free article. Review.
Plasma YKL-40 in patients with metastatic colorectal cancer treated with first line oxaliplatin-based regimen with or without cetuximab: RESULTS from the NORDIC VII Study.
Tarpgaard LS, Guren TK, Glimelius B, Christensen IJ, Pfeiffer P, Kure EH, Sorbye H, Ikdahl T, Yilmaz M, Johansen JS, Tveit KM. Tarpgaard LS, et al. Among authors: tveit km. PLoS One. 2014 Feb 3;9(2):e87746. doi: 10.1371/journal.pone.0087746. eCollection 2014. PLoS One. 2014. PMID: 24498368 Free PMC article. Clinical Trial.
Cetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII study.
Guren TK, Thomsen M, Kure EH, Sorbye H, Glimelius B, Pfeiffer P, Österlund P, Sigurdsson F, Lothe IMB, Dalsgaard AM, Skovlund E, Christoffersen T, Tveit KM. Guren TK, et al. Among authors: tveit km. Br J Cancer. 2017 May 9;116(10):1271-1278. doi: 10.1038/bjc.2017.93. Epub 2017 Apr 11. Br J Cancer. 2017. PMID: 28399112 Free PMC article. Clinical Trial.
140 results